To reduce hepatic blood flow and decrease portal pressures in persons with cirrhosis, the nurse should be prepared to administer which of the following medications?
A)
Bevacizumab, an angiogenesis inhibitor
B)
Octreotide, a long-acting synthetic analog of somatostatin
C)
Filgrastim, granulocyte colony-stimulating factor (G-CSF) analog
D)
Diltiazem (Cardizem), a calcium channel blocker
Ans:
B
Feedback:
Ocetrotide, a long-acting synthetic analog of somatostatin, reduces splanchnic and hepatic blood flow and portal pressures in persons with cirrhosis. Bevacizumab was the first angiogenesis inhibitor that was shown to slow tumor growth and, more importantly, to extend the lives of patients with some cancers. Filgrastim rapidly reverses neutropenia and maintains normal ANC in patients with HIV infection. Diltiazem is used to treat a variety of conditions, such as high blood pressure, migraines, and Raynaud disease.
You might also like to view...
The nurse is reviewing electrolytes and their functions with a client who has a history of electrolyte imbalance. One of the major cations noted in teeth and bones is:
1. Magnesium. 2. Calcium. 3. Potassium. 4. Phosphorus.
A nurse is providing care for a client who is immunocompromised following chemotherapy. The nurse knows which of the following characterizations of the adaptive immune system listed below is responsible for the client's disruption in his normal immune fun
A) Epitopes on antigens are recognized by immunoglobulin receptors following presentation by accessory cells. B) Haptens combine to form epitopes that stimulate the response of regulatory and effector cells. C) Effector cells orchestrate the immune response of regulatory cells toward an antigen. D) Accessory cells such as macrophages are engulfed by regulatory cells, stimulating effector cells.
A woman carries a recessive gene for sickle cell anemia. If her sexual partner also has this recessive gene, the chance that her first child will develop sickle cell anemia is
A) 1 in 4. B) 2 in 4. C) 3 in 4. D) 0 in 4.
Conversion of fat-soluble wastes to water-soluble material for renal excretion is a function of the:
a. gallbladder. b. kidney. c. liver. d. pancreas.